Anti-ROR1 antibody and use thereof
US12122830B1 · kind B1 · utility
0Cited by
29References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2019 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | May 11, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses an anti-ROR1 antibody specifically recognizing human and mouse ROR1. The monoclonal antibody can be usefully used for cancer targeting treatment including detection of various cancer expressing ROR1 through specific binding, and drug delivery to specific cancer, etc. as well as a cancer therapeutic agent, by inhibiting tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.